-transparent.png){kind=logo}
Depressed PMN chemotactic responsiveness was observed in 17.5% of 97 patients studied, depressed PMN bactericidal activity in 23.3% of 30 patients, and depressed PMN chemiluminescence activity in 15.8% of 19 patients. Depressed chemotactic
Related Publications
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
October 1979,
The Journal of pediatrics,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
January 1980,
The Annals of otology, rhinology & laryngology. Supplement,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
November 1985,
International journal of pediatric otorhinolaryngology,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
April 1982,
Infection and immunity,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
July 1989,
Journal of chemotherapy (Florence, Italy),
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
March 1986,
Pediatric emergency care,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
December 1957,
Canadian Medical Association journal,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
March 2003,
JAMA,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
March 2003,
JAMA,
G S Giebink, and
E L Mills, and
J S Huff, and
K L Cates, and
S K Juhn, and
P G Quie
March 2003,
JAMA,
